February 8, 2025
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

Casgevy uses the Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *